proactiveinvestors.co.uk · Nov 12, 2025
Verici Dx rises after passing key US laboratory accreditation audit
Verici Dx PLC (AIM:VRCI) shares were up as much as 11% in early trading after the diagnostics company announced it had successfully completed its second biennial inspection by the College of American Pathologists (CAP), one of the leading US bodies for clinical laboratory accreditation. The inspection passed with no deficiencies, confirming the company's continued compliance with CAP's rigorous quality and operational standards.
